Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1378925 | Bioorganic & Medicinal Chemistry Letters | 2005 | 6 Pages |
Abstract
Optimization on a series of piperazinebenzylamines resulted in analogues with low nanomolar binding at the human MC4 receptor but weak affinity (Ki > 500 nM) at the MC3 receptor. Compound 14c was identified to be a potent MC4R antagonist (Ki = 3.2 nM) with a selectivity of 240-fold over MC3R. It proved to be an insurmountable antagonist in a cAMP assay. Compound 14c potently stimulated food intake in satiated mice when given by intracerebroventricular administration.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Joseph Pontillo, Joseph A. Tran, Stacy Markison, Margaret Joppa, Beth A. Fleck, Dragan Marinkovic, Melissa Arellano, Fabio C. Tucci, Marion Lanier, Jodie Nelson, John Saunders, Sam R.J. Hoare, Alan C. Foster, Chen Chen,